Both in Biotechnology
Eloxx Pharmaceuticals vs Kalaris Therapeutics
Over the past year ELOX returned −17.5% and KLRS returned −37.3%; their daily moves had a correlation of 0.35.
ELOX −17.5% KLRS −37.3%Growth of $1, one year, split-adjusted
| Metric | ELOX | KLRS |
|---|---|---|
| Price | $13.00 | $2.12 |
| Market cap | $52.5M | $50.5M |
| Today | +1.25% | +6.00% |
| 1 month | −15.6% | −25.1% |
| 6 months | — | −60.0% |
| Year to date | — | −74.9% |
| 1 year | — | −57.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $62.0M | $93.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 57.4% |
| Short % of float | 1.3% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).